Literature DB >> 3391503

Correlation of hepatocyte HBsAg expression with virus replication and liver pathology.

H C Hsu1, M Y Lai, I J Su, D S Chen, M H Chang, P M Yang, C Y Wu, H C Hsieh.   

Abstract

To elucidate the biologic significance of hepatocyte HBsAg, its expression patterns were correlated with virus replication and liver pathology in 578 liver biopsies taken from chronic HBsAg carriers aged 1 to 80 years. Five major patterns of hepatocyte HBsAg were identified: homogeneous [intense and discrete, (Pattern A), faint and discrete, (Pattern B) and faint and grouped (Pattern C)]; globular or spotty (Pattern D), and marginal (Pattern E). Pattern A was always associated with viremia and also very frequently with membrane HBsAg expression, but rarely with active liver disease. It occurred most commonly in HBeAg-positive carrier children and young adults, reflecting an early immune tolerance phase with active virus replication. Pattern B was also usually associated with viremia, but very commonly associated with active disease (70%), reflecting active virus replication with enhanced immune response. Pattern E (marginal HBsAg), which was always in group distribution resembling a clonal expansion, predominated the HBeAg-negative phase and was associated with absence of viremia and occurred mostly in older adults with inactive bipolar disease spectrum (normal liver/mild disease or cirrhosis/hepatocellular carcinoma); this reflects a late phase of inactive virus replication or integration. Patterns C and D did not correlate well with viremia, but also tended to have inactive diseases as did Pattern E. These findings suggest that hepatocyte HBsAg expression is closely related to the natural course of chronic hepatitis B virus infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3391503     DOI: 10.1002/hep.1840080408

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

1.  Hepatitis C: a possible etiology for cryoglobulinaemia type II.

Authors:  A Pechère-Bertschi; L Perrin; P de Saussure; J J Widmann; E Giostra; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy.

Authors:  Tung-Hung Su; Chun-Jen Liu; Hung-Chih Yang; Yung-Ming Jeng; Huei-Ru Cheng; Chen-Hua Liu; Tai-Chung Tseng; Thai-Yen Ling; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  J Gastroenterol       Date:  2013-06-05       Impact factor: 7.527

3.  Analysis of intrahepatic HBVDNA in serologic HBV markers-negative or HBsAg-negative patients with chronic hepatitis.

Authors:  Y Y Zhang; Z Q Yu; L J Hao
Journal:  J Tongji Med Univ       Date:  1992

4.  A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals.

Authors:  F ter Borg; F J ten Kate; H T Cuypers; A Leentvaar-Kuijpers; J Oosting; P M Wertheim-van Dillen; P Honkoop; M C Rasch; R A de Man; J van Hattum; R A Chamuleau; G N Tytgat; E A Jones
Journal:  J Clin Pathol       Date:  2000-07       Impact factor: 3.411

5.  Hepatocyte necrosis associated with HBV marker expression and T cytotoxic cells in situ in chronic hepatitis B.

Authors:  Y Y Zhang; L J Hao
Journal:  J Tongji Med Univ       Date:  1989

6.  Intrahepatic HBVDNA replication and gene products expression correlated with foci of hepatic necrosis.

Authors:  Y Y Zhang; P Yan; Y K Wang; L Li; L J Hao
Journal:  J Tongji Med Univ       Date:  1990

7.  Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress.

Authors:  Hui-Ching Wang; Han-Chieh Wu; Chien-Fu Chen; Nelson Fausto; Huan-Yao Lei; Ih-Jen Su
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 8.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

9.  Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection.

Authors:  C M Chu; C T Yeh; Y F Liaw
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

Review 10.  Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.

Authors:  Andrew Vaillant
Journal:  Viruses       Date:  2021-04-23       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.